Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Treatment of Epstein Barr virus-induced haemophagocytic lymphohistiocytosis with rituximab-containing chemo-immunotherapeutic regimens
Authors
Keywords
-
Journal
BRITISH JOURNAL OF HAEMATOLOGY
Volume 162, Issue 3, Pages 376-382
Publisher
Wiley
Online
2013-05-21
DOI
10.1111/bjh.12386
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Anti-CD20 Antibody Therapy for B-Cell Lymphomas
- (2012) David G. Maloney NEW ENGLAND JOURNAL OF MEDICINE
- Familial and Acquired Hemophagocytic Lymphohistiocytosis
- (2011) G.E. Janka Annual Review of Medicine
- Perforin is a critical physiologic regulator of T-cell activation
- (2011) J. E. Lykens et al. BLOOD
- Hemophagocytic lymphohistiocytosis
- (2011) Kimberly Risma et al. CURRENT OPINION IN PEDIATRICS
- Primary immunodeficiency diseases associated with increased susceptibility to viral infections and malignancies
- (2011) Nima Rezaei et al. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
- Treatment choice of immunotherapy or further chemotherapy for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis
- (2011) Akira Shiraishi et al. PEDIATRIC BLOOD & CANCER
- Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2
- (2010) M. Meeths et al. BLOOD
- Clinical similarities and differences of patients with X-linked lymphoproliferative syndrome type 1 (XLP-1/SAP deficiency) versus type 2 (XLP-2/XIAP deficiency)
- (2010) J. P. Schmid et al. BLOOD
- X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease
- (2010) C. Booth et al. BLOOD
- Treatment advances in posttransplant lymphoproliferative disease
- (2010) Courtney D DiNardo et al. CURRENT OPINION IN HEMATOLOGY
- Treatment of Epstein-Barr Virus-related Hemophagocytic Lymphohistiocytosis (EBV-HLH); Update 2010
- (2010) Shinsaku Imashuku JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY
- Late-Onset Neutropenia After Rituximab Treatment
- (2010) Ofir Wolach et al. MEDICINE
- Rate of decline of ferritin in patients with hemophagocytic lymphohistiocytosis as a prognostic variable for mortality
- (2010) Tiffany F. Lin et al. PEDIATRIC BLOOD & CANCER
- Familial Hemophagocytic Lymphohistiocytosis Type 5 (FHL-5) Is Caused by Mutations in Munc18-2 and Impaired Binding to Syntaxin 11
- (2009) Udo zur Stadt et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Munc18-2 deficiency causes familial hemophagocytic lymphohistiocytosis type 5 and impairs cytotoxic granule exocytosis in patient NK cells
- (2009) Marjorie Côte et al. JOURNAL OF CLINICAL INVESTIGATION
- Infection of T lymphocytes in Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children of non-Asian origin
- (2009) Karin Beutel et al. PEDIATRIC BLOOD & CANCER
- Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis
- (2007) Carl E. Allen et al. PEDIATRIC BLOOD & CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now